Alba Bergas

Identification and validation of clinical phenotypes with prognostic implications in patients admitted to hospital with COVID-19: a multicentre cohort study

Belén Gutiérrez‐Gutiérrez, Alberto M. Borobia, Antonio J. Carcas et al. · The Lancet Infectious Diseases · 2021 · 102 citations · Full text

Medicine, Clinical Sciences, Infectious Diseases +13

Impact of the Inclusion of an Aminoglycoside to the Initial Empirical Antibiotic Therapy for Gram-Negative Bloodstream Infections in Hematological Neutropenic Patients: a Propensity-Matched Cohort Study (AMINOLACTAM Study)

Adaia Albasanz‐Puig, Carlota Gudiol, Pedro Puerta‐Alcalde et al. · Antimicrobial Agents and Chemotherapy · 2021 · 48 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +16

Real-Life Use of Ceftolozane/Tazobactam for the Treatment of Bloodstream Infection Due to Pseudomonas aeruginosa in Neutropenic Hematologic Patients: a Matched Control Study (ZENITH Study)

Alba Bergas, Adaia Albasanz‐Puig, Ana Fernández‐Cruz et al. · Microbiology Spectrum · 2022 · 32 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +14

Immunomodulatory therapy, risk factors and outcomes of hospital-acquired bloodstream infection in patients with severe COVID-19 pneumonia: a Spanish case–control matched multicentre study (BACTCOVID)

Gabriela Abelenda-Alonso, Alexander Rombauts, Carlota Gudiol et al. · Clinical Microbiology and Infection · 2021 · 29 citations · Full text

Veterinary Medicine, Infectious Diseases, Microbiology +14

Effect of Combination Antibiotic Empirical Therapy on Mortality in Neutropenic Cancer Patients with Pseudomonas aeruginosa Pneumonia

Adaia Albasanz‐Puig, Xavier Durà-Miralles, Júlia Laporte-Amargós et al. · Microorganisms · 2022 · 14 citations · Full text

Pharmacy, Infectious Diseases, Oncology +16